Continued strong financial results and cash generation, achieving all 2025 guidance metrics Full year earnings growth; GAAP EPS up 3%, Adjusted EPS up 19% Returned $791 million to shareholders through share repurchases and dividends Multi-year financial framework focused on growth in revenue, earnings, and cash flow BOCA RATON, Fla., March 02, 2026 (GLOBE NEWSWIRE) — ADT Inc. (NYSE: ADT), a leading provider of security, interactive, and smart home solutions serving residential and small business customers in the U.S., today reported results for the fourth quarter and full year of 2025. Financial highlights for the fourth quarter and full year are below with variances on a year-over-year basis unless otherwise noted. Results of the former commercial and solar businesses are presented as discontinued operations, except for cash...

MIAMI, March 02, 2026 (GLOBE NEWSWIRE) — Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (together with NCL Corporation Ltd. (“NCLC”), “Norwegian Cruise Line Holdings”, “Norwegian”, “NCLH” or the “Company”) today reported financial results for the fourth quarter and full year ended December 31, 2025, and provided guidance for the first quarter and full year 2026. HighlightsGrew total revenue 3.7% to $9.8 billion in 2025. GAAP net income was $423.2 million, with EPS of $0.92. Delivered Adjusted EBITDA1 of $2.73 billion in 2025, exceeding guidance, and representing an increase of 11% compared to 2024. Adjusted Net Income grew 15% to $1.045 billion. Adjusted EPS grew 19% to $2.11. Company sets full year 2026 guidance with Adjusted EPS expected to be $2.38. Company completed first phase of enhancements to Great Stirrup Cay, the...

Total Company Revenue increased 14.8% to a quarterly record of $547.7 million in the fourth quarter of 2025 from $477.1 million in the fourth quarter of 2024; Revenue from the Digital Health reportable segment (inclusive of intersegment revenue) increased 48.2% to $27.9 million in the fourth quarter of 2025 from $18.9 million in the fourth quarter of 2024 Total Company Adjusted EBITDA(1) was a quarterly record of $87.7 million in the fourth quarter of 2025 as compared with $75.0 million in the fourth quarter of 2024, an increase of 16.9%; Digital Health reportable segment Adjusted EBITDA(1) increased 8.9% to $4.9 million in the fourth quarter of 2025 from $4.5 million in the fourth quarter of 2024 Total Company Adjusted EBITDA(1) margins increased by 29 bps to 16.0% in the fourth quarter of 2025 as compared with 15.7% in the fourth quarter...

VANCOUVER, British Columbia, March 02, 2026 (GLOBE NEWSWIRE) — K92 Mining Inc. (“K92” or the “Company”) (TSX: KNT; OTCQX: KNTNF) is pleased to announce financial results for the three and twelve months ended December 31, 2025. ProductionFourth Quarter 2025Strong quarterly production of 47,178 ounces gold equivalent (“AuEq”)(1) or 44,129 oz gold, 1,940,781 lbs copper and 47,427 oz silver. Cash costs of US$768/oz gold, and all-in sustaining costs (“AISC”) of US$1,619/oz gold (3). Record quarterly ore processed of 186,198 tonnes, a 93% increase from Q4 2024, with a head grade of 8.0 grams per tonne (“g/t”) AuEq, or 7.4 g/t gold, 0.5% copper and 10 g/t silver, with a moderate positive gold and copper grade reconciliation versus the latest independent mineral resource estimate (September 12, 2023 effective date for Kora and Judd). Strong...

Supplemental Biologics License Application for Ziihera® (zanidatamab-hrii) to be completed by our partner Jazz in first-line HER2-positive (HER2+) gastroesophageal adenocarcinoma (GEA) during 1Q 2026 in the U.S. with potential launch in 2H 2026 Up to $440.0 million in milestone payments eligible to be earned related to regulatory approvals of Ziihera in GEA in the U.S., Europe, Japan, and China Additional clinical data for pasritamig in prostate cancer presented at ASCO-GU in February 2026 by Johnson & Johnson Innovative Medicine (J&J) $62.5 million utilized for share repurchases as of March 2, 2026 under the current authorized share repurchase program $250.0 million non-recourse royalty-backed note financing from Royalty Pharma to provide non-dilutive capital to support the ongoing stock repurchase program, potential strategic...

Following positive topline results from the pivotal, global Phase 3 DRAGON trial of tinlarebant in adolescents with Stargardt disease type 1 (STGD1), the Company is on track to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in Q2 2026 Completed enrollment in the Phase 2/3 DRAGON II trial in STGD1 Completed a $402 million underwritten public offering of American Depositary Shares Conference call and webcast on Monday, March 2, 2026, at 4:30 p.m. ETSAN DIEGO, March 02, 2026 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced its preliminary, unaudited financial results for the fourth...

DALLAS, March 02, 2026 (GLOBE NEWSWIRE) — Kosmos Energy Ltd. (“Kosmos” or the “Company”) (NYSE/LSE: KOS) announced today its financial and operating results for the fourth quarter of 2025. For the quarter, the Company generated a net loss of $377 million, or $0.79 per diluted share. When adjusted for certain items that impact the comparability of results, the Company generated an adjusted net loss(1) of $78 million, or $0.16 per diluted share for the fourth quarter of 2025. FOURTH QUARTER 2025 AND POST QUARTER END HIGHLIGHTSZero lost-time injuries or total recordable injuries in 2025Net Production(2): ~67,900 barrels of oil equivalent per day (boepd), up ~4% versus third quarter 2025, with sales of ~62,900 boepdRevenues: $295 million, or $50.88 per boe (excluding the impact of derivative cash settlements)Production expense:...

Bergen, Norway, 2 March 2026: Lerøy Seafood Group ASA (“Lerøy”) today presents an updated strategy and clear financial targets towards 2030 at its Capital Markets Day (CMD). Building on a fully integrated seafood value chain, strengthened biological performance and a disciplined investment programme, Lerøy enters a new phase focused on scalable growth, structural cost reductions and improved capital efficiency. The strategy is anchored in four priorities — Growth, Cost, Simplify and Leadership —through the Lerøy Way execution model and supported by a sharpened capital allocation framework. Lerøy Seafood Group targets towards 2030:NOK 50 billion in revenues   NOK 2 billion EBIT in VAP S&D Targeting NOK 1 billion in reduced cost base through initiatives in 2026Targeting NOK 1 billion in reduced cost base through initiatives in 2026 15%...

BEIJING, China, March 01, 2026 (GLOBE NEWSWIRE) — Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that it delivered 26,421 vehicles in February 2026. As of February 28, 2026, Li Auto’s cumulative deliveries reached 1,594,304. Li Auto officially rolled out OTA update version 8.3 ahead of the Chinese Spring Festival, featuring comprehensive upgrades in three key areas: VLA Driver large model, smart cockpit and smart electric functionality. During the Spring Festival travel peak, the Company provided users with a stable and convenient energy replenishment experience through its nationwide network of more than 4,000 super charging stations. From February 14 to February 23, 2026, the Company powered over 1.45 million charging sessions, with total charging...

HighlightsSQM reported total revenues for the twelve months ended December 31, 2025 of US$4,576.2 million compared to total revenues of US$4,528.8 million for the same period last year.Net income for the twelve months ended December 31, 2025 of US$588.1 million or US$2.06 per share, compared to net loss of US$(404.4) million or US$(1.42) per share for the same period last year.In lithium: Record quarterly sales volumes amidst strong market demandStrong price environment in iodine SQM will hold a conference call to discuss these results on Monday, March 2, 2026 at 10:00am EST (12:00pm Chile time).Participant Call link:https://register-conf.media-server.com/register/BI256bddfcaae643f591a9cfc6b2a449d6Webcast:https://edge.media-server.com/mmc/p/f6nxktxeSANTIAGO, Chile, Feb. 27, 2026 (GLOBE NEWSWIRE)...